Clinical trial
A Pilot Study Of Interferon Alpha 2b Plus Ribavirin In The Treatment Of Patients With Chronic Hepatitis B
NCT00275938 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study Of Interferon Alpha 2b Plus Ribavirin In The Treatment Of Patients With Chronic Hepatitis B
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 31, 1998
- Completion date
- June 30, 2001
- Enrollment
- 120
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic hepatitis b